InsidersTradesSigma
Total declarations
Companies
▲ Purchases (14 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
14
Disclosed sells
3
T+90 hit rate
25%
T+90 mean return
-9.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Parker Geoffrey M., Director. Director active across 6 companies, notably PERRIGO Co plc. In total, 37 disclosures have been published. Breakdown: 14 buys · 3 sells. Total volume traded: €1.1m. History available since 7 May 2021. The latest transaction was filed on 14 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Parker Geoffrey M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations37 total
7,305 shares@ US$10.840.0035% mcap5.3% of flowOrdinary SharesSEC:0001585364-26-000075:0
24,001 shares@ US$1.7647.2% of flowCommon StockSEC:0001737287-26-000007:0
7,500 shares@ US$14.184.1% of flowOrdinary SharesSEC:0001491874-25-000007:0
Canonical exit: 10 Feb 2026 (T+90)
36,744 shares@ US$1.2565100.0% of flowCommon StockSEC:0001737287-25-000091:0
4,375 shares@ US$22.97080.0045% mcap6.7% of flowOrdinary SharesSEC:0001585364-25-000130:0
Canonical exit: 16 Nov 2025 (T+90)
4,375 shares@ US$22.97084.0% of flowOrdinary SharesSEC:0001585364-25-000128:0
Canonical exit: 16 Nov 2025 (T+90)
9,904 shares@ US$26.019.0% of flowOrdinary SharesSEC:0001585364-25-000074:0
3,500 shares@ US$27.103.3% of flowOrdinary SharesSEC:0001585364-25-000058:0
Canonical exit: 10 Aug 2025 (T+90)
4,361 shares@ US$1.730.7% of flowCommon StockSEC:0001737287-25-000019:0
173,913 shares0Common StockSEC:0001737287-25-000008:0
36,404 shares@ US$2.849.3% of flowCommon StockSEC:0001737287-24-000065:0
344,828 shares@ US$2.9089.9% of flowCommon StockSEC:0001593968-24-000715:0
8,764 shares@ US$30.229.5% of flowOrdinary SharesSEC:0001585364-24-000090:0
190 shares@ US$3.5950.1% of flowCommon StockSEC:0001593968-24-000449:0
Canonical exit: 29 Apr 2024 (T+90)
29,400 shares0Common StockSEC:0001593968-24-000195:0
3,750 shares0Common StockSEC:0000950170-23-071958:0
400,000 shares0Common StockSEC:0001593968-23-001369:0
390,000 shares0Common StockSEC:0001593968-23-001369:1
685,025 shares@ €0.664849.3% of flowCommon StockSEC:0000950170-23-035679:0
Canonical exit: 25 Oct 2023 (T+90)
10,000 shares@ US$33.063711.9% of flowOrdinary SharesSEC:0001585364-23-000106:0
Canonical exit: 11 Sept 2023 (T+90)
7,778 shares@ US$32.869.2% of flowOrdinary SharesSEC:0001585364-23-000096:0
303,030 shares@ €0.75924.9% of flowCommon StockSEC:0000899243-23-011188:0
Canonical exit: 9 Jul 2023 (T+90)
5,000 shares@ US$38.0547.0% of flowOrdinary SharesSEC:0001585364-23-000008:0
Canonical exit: 4 Jun 2023 (T+90)
107,997 sharesCommon StockSEC:0000899243-22-034084:0
25,000 shares@ €1.389614.5% of flowCommon StockSEC:0000899243-22-022382:0
Canonical exit: 11 Sept 2022 (T+90)
25 of 37 declarations
About Parker Geoffrey M.
Parker Geoffrey M. is Director at PERRIGO Co plc, Director at Better Therapeutics, Inc., Director at ChemoCentryx, Inc., Chief Financial Officer at Allogene Therapeutics, Inc., and COO, CFO and EVP at Tricida, Inc. He has 37 filings in total. In the recent filings available, covering the period from 2016-01-11 to 2026-05-15, buys amount to EUR 998861 and sells to EUR 82811, with a modal transaction nature listed as Acquisition.
